首页> 外文期刊>Modern Pathology >Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases
【24h】

Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases

机译:臂丛动物在脊索瘤与透明细胞肾细胞癌和生殖细胞肿瘤鉴别中的特异性:305例研究

获取原文
           

摘要

Brachyury is recognized as a specific marker for notochord-derived tissues and neoplasms, and has become a defining immunohistochemical feature of chordoma. The main differential diagnostic consideration for chordoma is chondrosarcoma, which is known to lack brachyury expression. However, within the spectrum of genitourinary neoplasia, metastatic germ cell tumors and clear cell renal cell carcinoma may also be close morphological mimics of chordoma, particularly given the increasing prevalence of small tissue samples from image-guided biopsies. Although immunoreactivity for brachyury has been reported in a few germ cell tumors, a thorough characterization of staining by specific subtype has not been performed in a large series. Additionally, brachyury expression in clear cell renal cell carcinoma has not been well studied. In this study, immunohistochemical expression with the brachyury antibody was evaluated in 111 germ cell tumors, 30 non-neoplastic and neoplastic (non-germ cell) testicular tissues, and 184 metastatic clear cell renal cell carcinomas using tissue microarray technology. In addition, immunoreactivity for PAX-8 and SALL-4 was evaluated in 12 chordomas on whole section. No nuclear brachyury expression was identified in any of the 101 germ cell tumors within the tissue microarray (including choriocarcinoma (1), embryonal carcinoma (20), intratubular germ cell neoplasia unclassified (2), seminoma (64), spermatocytic seminoma (1), teratoma (5) and yolk sac tumor (8)), in any of the 30 non-neoplastic and neoplastic (non-germ cell) testicular tissues, or in any of the 10 whole-section seminomas. All 184 metastatic clear cell renal cell carcinomas were also non-reactive for brachyury. All 12 chordomas showed strong nuclear immunoreactivity for brachyury, but no expression of SALL-4. In all, 1 of 12 chordoma cases showed patchy, 1+ nuclear immunoreactivity for PAX-8. This study confirms the specificity of brachyury for chordoma in the differential diagnostic distinction from the potential genitourinary mimics, germ cell tumors and metastatic clear cell renal cell carcinoma.
机译:Brachyury被认为是脊索来源的组织和肿瘤的特异性标志物,并已成为脊索瘤的定义性免疫组织化学特征。脊索瘤的主要鉴别诊断考虑因素是软骨肉瘤,已知缺乏软骨肉瘤的表达。但是,在泌尿生殖系肿瘤的范围内,转移性生殖细胞肿瘤和透明细胞肾细胞癌也可能是脊索瘤的近似形态学模拟,特别是考虑到图像引导的活检组织中小组织样本的患病率日益上升。尽管在少数生殖细胞肿瘤中已报道了对近亲神经的免疫反应性,但尚未在大系列中对特定亚型的染色进行全面的表征。另外,在透明细胞肾细胞癌中短臂神经节的表达还没有得到很好的研究。在这项研究中,使用组织芯片技术评估了111种生殖细胞肿瘤,30种非肿瘤和赘生性(非生殖细胞)睾丸组织以及184种转移性透明细胞肾细胞癌中含有brachyury抗体的免疫组织化学表达。另外,在整个切片上的12个脊索瘤中评估了对PAX-8和SALL-4的免疫反应性。在组织微阵列内的101种生殖细胞肿瘤(包括绒毛膜癌(1),胚胎癌(20),未分类的肾小管内生殖细胞瘤(2),精原细胞瘤(64),精细胞精原细胞瘤(1))中,未鉴定出核短肌表达。 ,睾丸畸胎瘤(5)和卵黄囊肿瘤(8))在30种非赘生性和赘生性(非生殖细胞)睾丸组织中的任何一种,或在10种整节性精原细胞瘤中的任何一种。所有184例转移性透明细胞肾细胞癌也均对短动脉瘤无反应。所有12个脊索瘤均显示出对短毛象的强核免疫反应性,但未表达SALL-4。总计,在12个脊索瘤病例中,有1个显示出对PAX-8的斑片状,1 +核免疫反应性。这项研究证实了布奇球菌对脊索瘤的特异性,可与潜在的泌尿生殖模拟物,生殖细胞肿瘤和转移性透明细胞肾细胞癌进行鉴别诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号